New York University Medical Oncology Associates

New York, New York 10016

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Glioblastoma, HER2 Low Breast Cancer, HER2-positive Breast Cancer, HER2-positive Colorectal Cancer, HER2-positive Gastric Cancer, HER2-positive Non-Small Cell Lung Cancer, HER2-positive Tumors, Melanoma, Metastatic Cancer

Studies at this site

• A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 — Stopped early
• Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer — Completed
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed